Satya Prasad Makula

Satya Prasad Makula

Director Director DIN 01873217
DIN 01873217 First appointment Apr 2006 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Apr 2006
Shareholding value β€’β€’β€’β€’ Premium profile

About Satya Prasad Makula

Data last updated:

Satya Prasad Makula was a Director at Medchem International Limited (2006–2011) and Managing Director at Viswa Bio-Sciences Private Limited (from 2017). The companies operate in Pharma.

DIN 01873217
Primary Designation Director
Industry Pharma
First Appointment 13 Apr 2006
Oldest Company Age 9 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medchem International Limited U24230TG2006PLC049813
Director13 Apr 20062006₹54.8 Lakh (FY 2024)Active
Viswa Bio-Sciences Private Limited U73100TG2017PTC119625
Managing Director19 Sep 20172017Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Viswa Bio-Sciences Private Limited
Medchem International Limited
Premium access

Shareholding and investment profile for Satya Prasad Makula

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Satya Prasad Makula

Satya Prasad Makula was first appointed on 13 Apr 2006 as Director at Medchem International Limited. The most recent appointment on record is 19 Sep 2017 at Viswa Bio-Sciences Private Limited.

Satya Prasad Makula held 2 earlier board appointments: Medchem International Limited (Director, 13 Apr 2006 to 15 Feb 2011); Viswa Bio-Sciences Private Limited (Managing Director, from 19 Sep 2017).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available